RWD61 Analysis of the National Database of the Russian Federation on the Safety of Medicines for Etiopathogenetic Treatment covid-19 in Clinical Practice (REAL-WORLD DATA; RWD)

Detalles Bibliográficos
Autores principales: Kolbin, A, Syraeva, GI, Mishinova, SA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232751/
http://dx.doi.org/10.1016/j.jval.2022.04.1585
_version_ 1784735662320123904
author Kolbin, A
Syraeva, GI
Mishinova, SA
author_facet Kolbin, A
Syraeva, GI
Mishinova, SA
author_sort Kolbin, A
collection PubMed
description
format Online
Article
Text
id pubmed-9232751
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92327512022-06-27 RWD61 Analysis of the National Database of the Russian Federation on the Safety of Medicines for Etiopathogenetic Treatment covid-19 in Clinical Practice (REAL-WORLD DATA; RWD) Kolbin, A Syraeva, GI Mishinova, SA Value Health Article Published by Elsevier Inc. 2022-07 2022-06-25 /pmc/articles/PMC9232751/ http://dx.doi.org/10.1016/j.jval.2022.04.1585 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Kolbin, A
Syraeva, GI
Mishinova, SA
RWD61 Analysis of the National Database of the Russian Federation on the Safety of Medicines for Etiopathogenetic Treatment covid-19 in Clinical Practice (REAL-WORLD DATA; RWD)
title RWD61 Analysis of the National Database of the Russian Federation on the Safety of Medicines for Etiopathogenetic Treatment covid-19 in Clinical Practice (REAL-WORLD DATA; RWD)
title_full RWD61 Analysis of the National Database of the Russian Federation on the Safety of Medicines for Etiopathogenetic Treatment covid-19 in Clinical Practice (REAL-WORLD DATA; RWD)
title_fullStr RWD61 Analysis of the National Database of the Russian Federation on the Safety of Medicines for Etiopathogenetic Treatment covid-19 in Clinical Practice (REAL-WORLD DATA; RWD)
title_full_unstemmed RWD61 Analysis of the National Database of the Russian Federation on the Safety of Medicines for Etiopathogenetic Treatment covid-19 in Clinical Practice (REAL-WORLD DATA; RWD)
title_short RWD61 Analysis of the National Database of the Russian Federation on the Safety of Medicines for Etiopathogenetic Treatment covid-19 in Clinical Practice (REAL-WORLD DATA; RWD)
title_sort rwd61 analysis of the national database of the russian federation on the safety of medicines for etiopathogenetic treatment covid-19 in clinical practice (real-world data; rwd)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232751/
http://dx.doi.org/10.1016/j.jval.2022.04.1585
work_keys_str_mv AT kolbina rwd61analysisofthenationaldatabaseoftherussianfederationonthesafetyofmedicinesforetiopathogenetictreatmentcovid19inclinicalpracticerealworlddatarwd
AT syraevagi rwd61analysisofthenationaldatabaseoftherussianfederationonthesafetyofmedicinesforetiopathogenetictreatmentcovid19inclinicalpracticerealworlddatarwd
AT mishinovasa rwd61analysisofthenationaldatabaseoftherussianfederationonthesafetyofmedicinesforetiopathogenetictreatmentcovid19inclinicalpracticerealworlddatarwd

Ejemplares similares